GoodRx (GDRX) announced the launch of a new subscription for hair loss treatment. Built for simplicity and transparency, GoodRx for Hair Loss helps men access affordable treatments that are clinically proven to slow hair loss and support regrowth. The all-in-one solution includes a virtual consultation, prescription medication if appropriate, and discreet home delivery, starting as low as $16 per month. “Hair loss is common, and treatment shouldn’t be complicated,” said Nitin Shingate, chief technology officer at GoodRx. “Our subscription gives men a simple, one-stop solution for transparent pricing, proven treatment options, and quick access to licensed healthcare professionals, all from a brand trusted by millions of Americans to get the care they deserve each year.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GDRX:
- Positive Growth Outlook for GoodRx Holdings Driven by Strategic Partnerships and De-risked Stock
- Trump Weekly: Generics to be excluded from pharma tariff plan
- Trump Trade: GoodRx, others in talks with White House to join TrumpRx
- GoodRx Stock (GDRX) Pops as U.S. Pharmacies Unite to Lobby for TrumpRx Participation
- GoodRx success to depend on navigating evolving market, says BofA
